Literature DB >> 557025

Medical treatment of the ductus arteriosus.

A M Rudolph, M A Heymann.   

Abstract

Prostaglandin administered by aortic infusion prevents ductus closure when this is desirable--as in term infants with pulmonary atresia or critical pulmonic stenosis--raising arterial oxygen tension to levels compatible with life. On the other hand, in prematures with persistent patency of the ductus, administering indomethacin inhibits prostaglandin sysnthesis, inducing closure, and can obviate surgery.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557025     DOI: 10.1080/21548331.1977.11707078

Source DB:  PubMed          Journal:  Hosp Pract        ISSN: 0018-5809


  4 in total

1.  Intermittent disappearance of a patent ductus arteriosus murmur: report of a case and review of the literature.

Authors:  D V Cokkinos; R D Leachman; R Lufschanowski
Journal:  Tex Heart Inst J       Date:  1982-03

2.  Maintaining patency of the ductus-arteriosus for palliation of cyanotic congenital cardiac malformations. The use of prostaglandin E1 and formaldehyde infiltration of the ductal wall.

Authors:  J Hatem; R M Sade; J K Upshur; A R Hohn
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

3.  Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.

Authors:  A C Gittenberger-de Groot; A J Moulaert; E Harinck; A E Becker
Journal:  Br Heart J       Date:  1978-03

Review 4.  Enteral Nutrition in Term Infants with Congenital Heart Disease: Knowledge Gaps and Future Directions to Improve Clinical Practice.

Authors:  Silvia Martini; Isadora Beghetti; Mariarosaria Annunziata; Arianna Aceti; Silvia Galletti; Luca Ragni; Andrea Donti; Luigi Corvaglia
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.